{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T02:49:46Z","timestamp":1784429386074,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.healun.2020.02.020","type":"journal-article","created":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T18:17:25Z","timestamp":1583000245000},"page":"287-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Biomarkers in pulmonary arterial hypertension: Moving closer toward precision medicine?"],"prefix":"10.1016","volume":"39","author":[{"given":"Manreet Kaur","family":"Kanwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2020.02.020_bib0001","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2020.02.020_bib0002","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2213-2600(17)30161-3","article-title":"Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study","volume":"5","author":"Rhodes","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.healun.2020.02.020_bib0003","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.healun.2020.02.020_bib0004","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.healun.2014.12.005","article-title":"Circulating biomarkers in pulmonary arterial hypertension: update and future direction","volume":"34","author":"Pezzuto","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2020.02.020_bib0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/469156a","article-title":"Bring on the biomarkers","volume":"469","author":"Poste","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.healun.2020.02.020_bib0006","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1378\/chest.12-1246","article-title":"Biomarkers in pulmonary hypertension: what do we know?","volume":"144","author":"Foris","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.healun.2020.02.020_bib0007","doi-asserted-by":"crossref","first-page":"136","DOI":"10.21693\/1933-088X-16.3.136","article-title":"Current and emerging biomarkers for pulmonary hypertension","volume":"16","author":"Hemnes","year":"2018","journal-title":"Adv Pulm Hypertens"},{"key":"10.1016\/j.healun.2020.02.020_bib0008","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01889-2018","article-title":"Risk stratification and medical therapy of pulmonary arterial hypertension","volume":"53","author":"Gali\u00e8","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2020.02.020_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211909","article-title":"Isolating pulmonary microvascular endothelial cells ex vivo: implications for pulmonary arterial hypertension, and a caution on the use of commercial biomaterials","volume":"14","author":"Wertheim","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2020.02.020_bib0010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1183\/09031936.00160307","article-title":"Biomarkers in pulmonary hypertension","volume":"32","author":"Warwick","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2020.02.020_bib0011","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1378\/chest.129.5.1313","article-title":"Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension","volume":"129","author":"Fijalkowska","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.healun.2020.02.020_bib0012","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2020.02.020_bib0013","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCHEARTFAILURE.110.958223","article-title":"High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure","volume":"4","author":"Ky","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2020.02.020_bib0014","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.healun.2019.12.002","article-title":"Circulating NEDD9 is increased in pulmonary arterial hypertension: a multicenter, retrospective analysis","volume":"39","author":"Samokhin","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2020.02.020_bib0015","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap7294","article-title":"NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension","volume":"10","author":"Samokhin","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.healun.2020.02.020_bib0016","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2020.02.020_bib0017","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00889-2017","article-title":"Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension","volume":"50","author":"Boucly","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2020.02.020_bib0018","doi-asserted-by":"crossref","unstructured":"Simpson CE, Damico RL, Hassoun PM, et al. Noninvasive prognostic biomarkers for left heart failure as predictors of survival in pulmonary arterial hypertension [e-pub ahead of print]. Chest. doi: 10.1016\/j.chest.2019.12.037. Accessed February 16, 2020.","DOI":"10.1016\/j.chest.2019.12.037"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324982031425X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324982031425X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:38:03Z","timestamp":1760949483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105324982031425X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S105324982031425X"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2020.02.020","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers in pulmonary arterial hypertension: Moving closer toward precision medicine?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2020.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}